Patient Risk Stratification Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

How Big Is the Patient Risk Stratification Market Expected to Be, and What Will Its Growth Rate Be?
The market size of patient risk stratification has seen exponential growth in recent years, escalating from a value of $2.15 billion in 2024 to $2.82 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 31.3%. The previous period's growth can be linked to the widespread adoption of digital technology, amplified risks, an aging population, increased medical errors, and a surge in the use of electronic health records (EHR).

The market size for patient risk stratification is projected to substantially increase over the next few years, expanding to $8.30 billion in 2029 at a compound annual growth rate (CAGR) of 31.0%. This projected development during the forecasted period can be linked to the growing middle-class populace and health insurance, a rise in chronic disease cases, the rising utilization of predictive analytics, an increasing emphasis on social determinants of health (SDOH), and an escalated use of technology. The predictable trends for this period include breakthroughs in analytics, artificial intelligence (AI), machine learning, technological enhancements, inventive tools, advancements in healthcare technology, wearable technology, and remote monitoring.

What Are the Primary Growth Drivers for the Patient Risk Stratification Market?
The rise in chronic diseases globally is set to boost the expansion of the patient risk stratification market. These diseases, characterized by their long duration, typically lasting more than three months, are increasingly prevalent due to factors such as an aging population, poor health habits, urban growth, environmental determinants, limited healthcare accessibility, financial inequality, and ramped-up stress levels. Patient risk stratification plays a crucial role in identifying different risk levels in individuals for chronic illnesses, providing a way forward for personalized treatment, early preemptive measures, liquid resource allocation, and enhanced health outcomes. For example, in January 2023, data from the National Center for Biotechnology Information (NCBI), an American National Library of Medicine, projected a 99.5% increase in individuals over 50 with at least one chronic illness from 71.522 million in 2020 to 142.66 million by 2050. Moreover, in September 2022, as per the 2022 Highlights released by the World Health Organization (WHO), a health institution based in Switzerland, it was reported that 74% of all deaths globally were attributed to chronic diseases, totaling 41 million annual casualties. Of these, cardiovascular diseases led to 17.9 million deaths, cancer to 9.3 million, chronic respiratory illnesses to 4.1 million, and diabetes to 2.0 million. Therefore, the increase in chronic diseases is a significant driver for the patient risk stratification market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20917&type=smp

Who Are the Dominant Companies Influencing Patient Risk Stratification Market Trends?
Major companies operating in the patient risk stratification market are Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Adobe Inc., Persistent Systems, NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation

What Are the Emerging Trends in the Patient Risk Stratification Industry?
Leading firms in the patient risk stratification market are prioritizing technological progress in healthcare, such as the use of artificial intelligence (AI) for disease screening. This approach enhances early detection, boosts patient outcomes, and lowers healthcare expenses by facilitating more precise risk evaluations and individualized treatment strategies. AI in disease screening employs intricate algorithms and machine learning to scrutinize medical data, thus enabling early disease detection and enhancing diagnostic precision through the rapid analysis of large data quantities. For example, in May 2024, WELL Health Technologies Corporation, a healthcare corporation based in Canada, together with its associated company HEALWELL AI, an organization also based in Canada that focuses on AI and data science for preventative care, rolled out WELL AI Decision Support (WAIDS). This support system targets rare diseases and has now expanded to include screening for chronic illnesses like kidney disease, hypertension, and diabetes. With the ability to identify over 100 diseases and offer risk stratification, it aids clinicians in pinpointing care deficiencies and obtaining actionable data at the care point.

What Are the Different Segmentations in the Patient Risk Stratification Market?
The patient risk stratification market covered in this report is segmented -

1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model
2) By Component: Software, Services
3) By Delivery Model: On-Premise, Cloud-Based
4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications
5) By End User: Healthcare Providers, Healthcare Payers, Other End Users

Subsegments:
1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models
2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models
3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models
4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/patient-risk-stratification-global-market-report

Which Region Is at the Forefront of the Patient Risk Stratification Market?
North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient risk stratification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Patient Risk Stratification Global Market Report?

- Market Size Analysis: Analyze the patient risk stratification Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the patient risk stratification Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall patient risk stratification market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the patient risk stratification market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20917

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.